Impaired eating-related quality of life in chronic rhinosinusitis.


Journal

International forum of allergy & rhinology
ISSN: 2042-6984
Titre abrégé: Int Forum Allergy Rhinol
Pays: United States
ID NLM: 101550261

Informations de publication

Date de publication:
03 2019
Historique:
received: 22 06 2018
revised: 03 10 2018
accepted: 17 10 2018
pubmed: 30 11 2018
medline: 18 1 2020
entrez: 29 11 2018
Statut: ppublish

Résumé

Despite the tremendous burden of smell and taste dysfunction in patients with chronic rhinosinusitis (CRS), objective measures of smell and taste fail to fully account for eating-related disruptions in CRS patient quality of life (QOL). In this study we sought to investigate the driving force behind impaired eating-related QOL in CRS patients. Adult CRS patients were prospectively enrolled and answered a series of surveys relating to smell, taste, overall sinus-specific QOL, and depression. Patients with both smell-related and taste-related eating complaints were considered to have impaired eating-related QOL. Clinical demographics, objective chemosensory scores, and endoscopy scores were collected. Seventy patients were enrolled and 23% showed impaired eating-related QOL. In multivariable analyses, patients with aspirin-exacerbated respiratory disease (AERD) showed 10.7 times higher odds of impaired eating-related QOL (odds ratio [OR] 10.72; 95% confidence interval [CI], 1.09 to 105.09; p = 0.042); meanwhile, for every 1-point increase in depression scores, the odds of impaired eating-related QOL increased by 1.3 (OR 1.31; 95% CI, 1.10 to 1.57; p = 0.003). For every 1-point decrease in orthonasal olfactory threshold, the odds of impaired eating-related QOL increased by 1.9 times (OR 1.85; 95% CI, 1.14 to 3.00; p = 0.013). Symptom scores, polyp status, endoscopic scores, and other olfactory measures did not remain significant after adjusting for other variables in forward-selection multivariable modeling. Disruptions in eating-related QOL cannot be fully explained by objective smell or taste testing alone. We identified AERD and depression as independent risk factors for greater odds of impaired eating-related QOL in CRS. Improved orthonasal threshold scores were independently associated with better eating-related QOL.

Sections du résumé

BACKGROUND
Despite the tremendous burden of smell and taste dysfunction in patients with chronic rhinosinusitis (CRS), objective measures of smell and taste fail to fully account for eating-related disruptions in CRS patient quality of life (QOL). In this study we sought to investigate the driving force behind impaired eating-related QOL in CRS patients.
METHODS
Adult CRS patients were prospectively enrolled and answered a series of surveys relating to smell, taste, overall sinus-specific QOL, and depression. Patients with both smell-related and taste-related eating complaints were considered to have impaired eating-related QOL. Clinical demographics, objective chemosensory scores, and endoscopy scores were collected.
RESULTS
Seventy patients were enrolled and 23% showed impaired eating-related QOL. In multivariable analyses, patients with aspirin-exacerbated respiratory disease (AERD) showed 10.7 times higher odds of impaired eating-related QOL (odds ratio [OR] 10.72; 95% confidence interval [CI], 1.09 to 105.09; p = 0.042); meanwhile, for every 1-point increase in depression scores, the odds of impaired eating-related QOL increased by 1.3 (OR 1.31; 95% CI, 1.10 to 1.57; p = 0.003). For every 1-point decrease in orthonasal olfactory threshold, the odds of impaired eating-related QOL increased by 1.9 times (OR 1.85; 95% CI, 1.14 to 3.00; p = 0.013). Symptom scores, polyp status, endoscopic scores, and other olfactory measures did not remain significant after adjusting for other variables in forward-selection multivariable modeling.
CONCLUSION
Disruptions in eating-related QOL cannot be fully explained by objective smell or taste testing alone. We identified AERD and depression as independent risk factors for greater odds of impaired eating-related QOL in CRS. Improved orthonasal threshold scores were independently associated with better eating-related QOL.

Identifiants

pubmed: 30485716
doi: 10.1002/alr.22242
pmc: PMC6397059
mid: NIHMS994360
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

240-247

Subventions

Organisme : NIDCD NIH HHS
ID : R01 DC005805
Pays : United States

Informations de copyright

© 2018 ARS-AAOA, LLC.

Références

Front Psychol. 2014 Jan 31;5:32
pubmed: 24550860
J Neurosci. 2006 Dec 6;26(49):12664-71
pubmed: 17151269
Int Forum Allergy Rhinol. 2017 Jan;7(1):50-55
pubmed: 27552523
Arch Otolaryngol Head Neck Surg. 2002 Apr;128(4):414-8
pubmed: 11926917
J Allergy Clin Immunol Pract. 2015 Sep-Oct;3(5):711-8
pubmed: 25858054
Otolaryngol Head Neck Surg. 2015 Apr;152(2 Suppl):S1-S39
pubmed: 25832968
Laryngoscope. 2018 Nov;128(11):2437-2442
pubmed: 29637564
Eur Arch Otorhinolaryngol. 2015 Jun;272(6):1403-16
pubmed: 25086864
Eur Arch Otorhinolaryngol. 2017 Mar;274(3):1487-1493
pubmed: 27830335
Ann Otol Rhinol Laryngol Suppl. 1995 Oct;167:17-21
pubmed: 7574265
Int Forum Allergy Rhinol. 2018 Jul;8(7):783-789
pubmed: 29569385
Am J Rhinol Allergy. 2009 Mar-Apr;23(2):139-44
pubmed: 19401037
AIDS. 1998 Sep 10;12(13):1667-74
pubmed: 9764787
Rhinology. 2003 Mar;41(1):2-6
pubmed: 12677732
Am J Rhinol Allergy. 2018 Jul;32(4):280-286
pubmed: 29682983
Int Forum Allergy Rhinol. 2018 Jul;8(7):777-782
pubmed: 29633540
Laryngoscope Investig Otolaryngol. 2018 Feb 21;3(2):94-99
pubmed: 29721540
Clin Otolaryngol. 2006 Apr;31(2):103-9
pubmed: 16620328
Allergy. 2013;68(5):659-65
pubmed: 23464577
Allergy Asthma Clin Immunol. 2014 Dec 11;10(1):64
pubmed: 25516728
Laryngoscope. 2003 Nov;113(11):1993-7
pubmed: 14603062
Brain Sci. 2018 May 04;8(5):
pubmed: 29734670
Int Forum Allergy Rhinol. 2016 Mar;6(3):293-8
pubmed: 26718315
Int Forum Allergy Rhinol. 2017 Jul;7(7):734-740
pubmed: 28519966
Chem Senses. 2016 Jul;41(6):479-86
pubmed: 27170667
Int Forum Allergy Rhinol. 2016 Apr;6(4):407-13
pubmed: 26678351
Med Care. 2003 Nov;41(11):1284-92
pubmed: 14583691
Rhinology. 1997 Dec;35(4):146-8
pubmed: 9532631

Auteurs

Nicholas R Rowan (NR)

Department of Otolaryngology-Head and Neck Surgery, Division of Rhinology and Sinus Surgery, Medical University of South Carolina, Charleston, SC.

Zachary M Soler (ZM)

Department of Otolaryngology-Head and Neck Surgery, Division of Rhinology and Sinus Surgery, Medical University of South Carolina, Charleston, SC.

Kristina A Storck (KA)

Department of Otolaryngology-Head and Neck Surgery, Division of Rhinology and Sinus Surgery, Medical University of South Carolina, Charleston, SC.

Florence Othieno (F)

Department of Otolaryngology-Head and Neck Surgery, Division of Rhinology and Sinus Surgery, Medical University of South Carolina, Charleston, SC.

Kimia G Ganjaei (KG)

Department of Otolaryngology-Head and Neck Surgery, Division of Rhinology and Sinus Surgery, Medical University of South Carolina, Charleston, SC.
Rutgers Robert Wood Johnson Medical School, Rutgers University, Piscataway, NJ.

Timothy L Smith (TL)

Department of Otolaryngology-Head and Neck Surgery, Division of Rhinology and Sinus/Skull Base Surgery, Oregon Health & Science University, Portland, OR.

Rodney J Schlosser (RJ)

Department of Otolaryngology-Head and Neck Surgery, Division of Rhinology and Sinus Surgery, Medical University of South Carolina, Charleston, SC.
Department of Surgery, Ralph H. Johnson VA Medical Center, Charleston, SC.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH